These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18024694)

  • 21. Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification.
    Parchi P; Strammiello R; Notari S; Giese A; Langeveld JP; Ladogana A; Zerr I; Roncaroli F; Cras P; Ghetti B; Pocchiari M; Kretzschmar H; Capellari S
    Acta Neuropathol; 2009 Nov; 118(5):659-71. PubMed ID: 19718500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene.
    Di Fede G; Catania M; Atzori C; Moda F; Pasquali C; Indaco A; Grisoli M; Zuffi M; Guaita MC; Testi R; Taraglio S; Sessa M; Gusmaroli G; Spinelli M; Salzano G; Legname G; Tarletti R; Godi L; Pocchiari M; Tagliavini F; Imperiale D; Giaccone G
    Acta Neuropathol Commun; 2019 Jan; 7(1):1. PubMed ID: 30606247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Creutzfeldt-Jakob disease-M232R with the cooccurrence of multiple prion strains, M1 + M2C + M2T: Report of an autopsy case.
    Shintaku M; Nakamura T; Kaneda D; Shinde A; Kusaka H; Takeuchi A; Kitamoto T
    Neuropathology; 2021 Jun; 41(3):206-213. PubMed ID: 33586250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI characteristics of sporadic CJD with valine homozygosity at codon 129 of the prion protein gene and PrPSc type 2 in Japan.
    Fukushima R; Shiga Y; Nakamura M; Fujimori J; Kitamoto T; Yoshida Y
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):485-7. PubMed ID: 14966171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A patient with MV2 subtype of sporadic Creutzfeldt-Jakob disease and atypical clinical presentation.
    Guerrero D; Martínez-Velilla N; Caballero MC; Mendióroz MT; Tuñón T; Masdeu J; Rodríguez A; Armstrong J; Ferrer I
    Clin Neuropathol; 2008; 27(6):408-13. PubMed ID: 19130739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 1 and type 2 human PrPSc have different aggregation sizes in methionine homozygotes with sporadic, iatrogenic and variant Creutzfeldt-Jakob disease.
    Kobayashi A; Satoh S; Ironside JW; Mohri S; Kitamoto T
    J Gen Virol; 2005 Jan; 86(Pt 1):237-240. PubMed ID: 15604452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein.
    Hainfellner JA; Parchi P; Kitamoto T; Jarius C; Gambetti P; Budka H
    Ann Neurol; 1999 Jun; 45(6):812-6. PubMed ID: 10360778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A French cluster of Creutzfeldt-Jakob disease: a molecular analysis.
    Beaudry P; Parchi P; Peoc'h K; Desbordes P; Dartigues JF; Vital A; Vital C; Capellari S; Gambetti P; Delasnerie-Lauprêtre N; Mary JY; Laplanche JL
    Eur J Neurol; 2002 Sep; 9(5):457-62. PubMed ID: 12220376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes.
    Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA
    Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
    Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
    Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemistry for the prion protein: comparison of different monoclonal antibodies in human prion disease subtypes.
    Kovács GG; Head MW; Hegyi I; Bunn TJ; Flicker H; Hainfellner JA; McCardle L; László L; Jarius C; Ironside JW; Budka H
    Brain Pathol; 2002 Jan; 12(1):1-11. PubMed ID: 11770893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sporadic Creutzfeldt-Jakob disease with MM1-type prion protein and plaques.
    Ishida C; Kakishima A; Okino S; Furukawa Y; Kano M; Oda Y; Nakanishi I; Makifuchi T; Kitamoto T; Yamada M
    Neurology; 2003 Feb; 60(3):514-7. PubMed ID: 12578942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease.
    Ironside JW; Head MW
    Curr Top Microbiol Immunol; 2004; 284():133-59. PubMed ID: 15148991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical features of genetic Creutzfeldt-Jakob disease with valine-to-isoleucine substitution at codon 180 on the prion protein gene.
    Ito Y; Sanjo N; Hizume M; Kobayashi A; Ohgami T; Satoh K; Hamaguchi T; Yamada M; Kitamoto T; Mizusawa H; Yokota T
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1055-1061. PubMed ID: 29382530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease.
    Castellani RJ; Colucci M; Xie Z; Zou W; Li C; Parchi P; Capellari S; Pastore M; Rahbar MH; Chen SG; Gambetti P
    Neurology; 2004 Aug; 63(3):436-42. PubMed ID: 15304573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene.
    Capellari S; Cardone F; Notari S; Schininà ME; Maras B; Sità D; Baruzzi A; Pocchiari M; Parchi P
    Neurology; 2005 Mar; 64(5):905-7. PubMed ID: 15753435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MM1-type sporadic Creutzfeldt-Jakob disease with unusually prolonged disease duration presenting with panencephalopathic-type pathology.
    Hoshino A; Iwasaki Y; Izumi M; Kimura S; Ibi T; Kitamoto T; Yoshida M; Hashizume Y; Sahashi K
    Neuropathology; 2008 Jun; 28(3):326-32. PubMed ID: 18248577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.